Cart
sales@molnova.com
BYAKANGELICIN(b)
CAS No. 482-25-7
BYAKANGELICIN(b)( —— )
Catalog No. M20452 CAS No. 482-25-7
BYAKANGELICINa main furanocoumarin constituent isolated and characterized as an aldose reductase inhibitorand is effective for the treatment of sugar cataracts and diabetic neuropathy and hence might be useful as a lead compound for the development of new type drugs for clinical use.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 84 | In Stock |
|
| 5MG | 69 | In Stock |
|
| 10MG | 117 | In Stock |
|
| 25MG | 188 | In Stock |
|
| 50MG | 276 | In Stock |
|
| 100MG | 421 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBYAKANGELICIN(b)
-
NoteResearch use only, not for human use.
-
Brief DescriptionBYAKANGELICINa main furanocoumarin constituent isolated and characterized as an aldose reductase inhibitorand is effective for the treatment of sugar cataracts and diabetic neuropathy and hence might be useful as a lead compound for the development of new type drugs for clinical use.
-
DescriptionBYAKANGELICINa main furanocoumarin constituent isolated and characterized as an aldose reductase inhibitorand is effective for the treatment of sugar cataracts and diabetic neuropathy and hence might be useful as a lead compound for the development of new type drugs for clinical use.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetReductase
-
RecptorAldose reductase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number482-25-7
-
Formula Weight334.32
-
Molecular FormulaC17H18O7
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (149.56 mM)
-
SMILESCOc1c2ccoc2c(OC[C@@H](O)C(C)(C)O)c2oc(=O)ccc12
-
Chemical Name7H-Furo(32-g)(1)benzopyran-7-one 9-(23-dihydroxy-3-methylbutoxy)-4-methoxy- (R)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yang J Luan X Gui H et al. Byakangelicin induces cytochrome P450 3A4 expression via transactivation of pregnane X receptors in human hepatocytes[J]. British Journal of Pharmacology 2010 162(2):441-451.
molnova catalog
related products
-
ALR2-IN-1
ALR2-IN-1 is a potent and selective ALR2 inhibitor with an IC50 value of 1.42 μM. ALR2-IN-1 possesses both antiglycemic and antioxidant activities and can be used to study the complications of diabetes.
-
Saikosaponin B2
Saikosaponin B2 acts on HCV E2 and inhibits infection by several genotypic strains and prevents binding of serum-derived HCV onto hepatoma cells.
-
Sulindac sulfone
Sulindac sulfone is a metabolite of the nonsteroidal anti-inflammatory drug sulindac. Sulindac sulfone is an inhibitor of aldose reductase (IC50 =367 nM).
